James Molloy
Stock Analyst at Alliance Global Partners
(0.56)
# 3,809
Out of 4,761 analysts
32
Total ratings
24.24%
Success rate
-38.44%
Average return
Main Sectors:
Stocks Rated by James Molloy
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| INTS Intensity Therapeutics | Initiates: Buy | $8.5 | $2.23 | +281.17% | 1 | Jan 13, 2025 | |
| VTVT vTv Therapeutics | Initiates: Buy | $35 | $20.20 | +73.27% | 1 | Dec 9, 2024 | |
| GOVX GeoVax Labs | Initiates: Buy | $15 | $1.67 | +798.20% | 1 | Nov 11, 2024 | |
| INMB INmune Bio | Initiates: Buy | $20 | $8.59 | +132.83% | 1 | Oct 21, 2024 | |
| SCLX Scilex Holding Company | Initiates: Buy | $14 | $0.33 | +4,145.00% | 1 | Oct 16, 2024 | |
| TNXP Tonix Pharmaceuticals Holding | Maintains: Buy | $600 → $1,100 | $9.17 | +11,895.64% | 7 | Jul 22, 2024 | |
| PED PEDEVCO | Initiates: Buy | $1.75 | $0.76 | +130.23% | 1 | Jul 17, 2024 | |
| PXS Pyxis Tankers | Initiates: Buy | $10 | $3.63 | +175.48% | 1 | Jul 17, 2024 | |
| IGC IGC Pharma | Initiates: Buy | $3.5 | $0.30 | +1,082.43% | 1 | Jul 17, 2024 | |
| CHRO Channel Therapeutics | Initiates: Buy | n/a | $1.68 | - | 1 | Jun 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $9 → $14 | $0.82 | +1,607.32% | 2 | Jan 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $30 | $1.36 | +2,105.88% | 1 | Dec 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $7.5 | $1.09 | +588.07% | 1 | Jul 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $20 | $5.78 | +246.02% | 1 | May 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $14 → $8 | $1.27 | +529.92% | 1 | Nov 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $10 → $7 | $3.01 | +132.56% | 2 | Nov 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $80 | $0.97 | +8,147.42% | 1 | Nov 1, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $16 | $1.57 | +919.11% | 1 | Nov 1, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $14 | $0.78 | +1,688.91% | 1 | Oct 20, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $15 | $0.92 | +1,532.21% | 1 | Oct 13, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $240 | $0.32 | +75,064.42% | 1 | Sep 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $150 | $1.68 | +8,828.57% | 1 | Aug 25, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $938 | $1.36 | +68,833.82% | 1 | Jun 1, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $25 | $3.17 | +688.64% | 1 | Oct 4, 2021 |
Intensity Therapeutics
Jan 13, 2025
Initiates: Buy
Price Target: $8.5
Current: $2.23
Upside: +281.17%
vTv Therapeutics
Dec 9, 2024
Initiates: Buy
Price Target: $35
Current: $20.20
Upside: +73.27%
GeoVax Labs
Nov 11, 2024
Initiates: Buy
Price Target: $15
Current: $1.67
Upside: +798.20%
INmune Bio
Oct 21, 2024
Initiates: Buy
Price Target: $20
Current: $8.59
Upside: +132.83%
Scilex Holding Company
Oct 16, 2024
Initiates: Buy
Price Target: $14
Current: $0.33
Upside: +4,145.00%
Tonix Pharmaceuticals Holding
Jul 22, 2024
Maintains: Buy
Price Target: $600 → $1,100
Current: $9.17
Upside: +11,895.64%
PEDEVCO
Jul 17, 2024
Initiates: Buy
Price Target: $1.75
Current: $0.76
Upside: +130.23%
Pyxis Tankers
Jul 17, 2024
Initiates: Buy
Price Target: $10
Current: $3.63
Upside: +175.48%
IGC Pharma
Jul 17, 2024
Initiates: Buy
Price Target: $3.5
Current: $0.30
Upside: +1,082.43%
Channel Therapeutics
Jun 18, 2024
Initiates: Buy
Price Target: n/a
Current: $1.68
Upside: -
Jan 4, 2024
Maintains: Buy
Price Target: $9 → $14
Current: $0.82
Upside: +1,607.32%
Dec 11, 2023
Initiates: Buy
Price Target: $30
Current: $1.36
Upside: +2,105.88%
Jul 17, 2023
Initiates: Buy
Price Target: $7.5
Current: $1.09
Upside: +588.07%
May 24, 2023
Reiterates: Buy
Price Target: $20
Current: $5.78
Upside: +246.02%
Nov 15, 2022
Maintains: Buy
Price Target: $14 → $8
Current: $1.27
Upside: +529.92%
Nov 4, 2022
Maintains: Buy
Price Target: $10 → $7
Current: $3.01
Upside: +132.56%
Nov 1, 2022
Initiates: Buy
Price Target: $80
Current: $0.97
Upside: +8,147.42%
Nov 1, 2022
Initiates: Buy
Price Target: $16
Current: $1.57
Upside: +919.11%
Oct 20, 2022
Initiates: Buy
Price Target: $14
Current: $0.78
Upside: +1,688.91%
Oct 13, 2022
Initiates: Buy
Price Target: $15
Current: $0.92
Upside: +1,532.21%
Sep 7, 2022
Initiates: Buy
Price Target: $240
Current: $0.32
Upside: +75,064.42%
Aug 25, 2022
Initiates: Buy
Price Target: $150
Current: $1.68
Upside: +8,828.57%
Jun 1, 2022
Initiates: Buy
Price Target: $938
Current: $1.36
Upside: +68,833.82%
Oct 4, 2021
Initiates: Buy
Price Target: $25
Current: $3.17
Upside: +688.64%